CD14+CD16− ((109/L), mean ± SD: acetate, 1.0 ± 0.7 versus citrate, 0.9 ± 0.8; P = 0.30) and CD14+CD16+ ((109/L), mean ± SD: acetate, 0.2 ± 0.2 versus citrate, 0.2 ± 0.1; P = 0.95) (Table 5, Figures 3(b) and 3(c)) subsets and pathologically activated neutrophils and monocytes with immunosuppressive capacities known to be expanded and linked to infectious events in HD patients a.k.a [20] PMN-MDSCs ((109/L), mean ± SD: acetate, 0.04 ± 0.1 versus citrate 0.03 ± 0.3; P = 0.35) remained unchanged (Table 4, Figure 3(d)). Here, CD14 is linked to Huntington disease.